Showing 511-520 of 4212 results for "".
DermWireTV: AAD VMX Highlights, Upneeq Launches for Ptosis
https://practicaldermatology.com/topics/practice-management/dermwiretv-aad-vmx-highlights-upneeq-launches-for-ptosis/19931/The American Academy of Dermatology's VMX format delivers updates on a range of hot topics in dermatology, including an update on the COVID-19 dermatology vaccine registry from Esther Freeman, MD and teledermatology from Jules Lipoff, MD. Upneeq, a newly launched oxymetazoline eyedrop from RVL pharmSkin Reactions: Understanding New Drug Adverse Effects
https://practicaldermatology.com/conferences/aad-summer-2021/skin-reactions-understanding-new-drug-adverse-effects/19975/In addition to needing to stay abreast of new drugs in dermatology, it's important for dermatologists to stay informed about new medications that come to market in general. Vinod Nambudiri, MD, MBA says there are often dermatology-related adverse events that need to be managed. He discusses new canc"Ask Me Anything" Mentorship Session With Dr. Sheila Barbarino
https://practicaldermatology.com/youngmd-connect/on-demand-virtual-sessions/ask-me-anything-mentorship-session-with-dr-sheila-barbarino/39880/Sheila Barbarino, MD, FACS, discusses the keys to her success using social media as a marketing tool for her practice, critical practice management issues, and more. YoungMD Connect is an editorially independent platform made possible by industry sponsorships. We would like to thank our gold platfDermWireTV: Sotyktu Approval, Cetaphil at 75, Psoriasis/Depression Link
https://practicaldermatology.com/topics/psoriasis/dermwiretv-sotyktu-approval-cetaphil-at-75-psoriasisdepression-link/20138/FDA has approved Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the oral treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. April Armstrong, MD discusses the first TYK-2 inhibitor approved for psoriasis. As Cetaphil (Galderma)DermwireTV: J&J Boosts Dermatology Pipeline; New Humira Biosimilar Launched
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-jj-boosts-dermatology-pipeline-new-humira-biosimilar-launched/24561/In this episode of DermwireTV, Johnson & Johnson makes a major acquisition to expand its dermatology treatment pipeline; the first high-concentration, citrate-free biosimilar to Humira is launched in the US; and in the C-Suite Chats feature, the CEO of Benev discusses the medical aesthetic markeBest practices to create demographic-targeted content
https://practicaldermatology.com/topics/practice-management/best-practices-to-create-demographic-targeted-content/18241/Invest in quality-oriented content development practices that can steer a digital marketing campaign towards better outcomes. This includes content distributed through various mediums. High-quality content with which people can identify and content with a human touch is critical for any digital markDermWireTV: Cassiopea NDA; Drew Barrymore and Paula Abdul Make Endorsements
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-cassiopea-nda-drew-barrymore-and-paula-abdul-make-endorsements/19654/BTL’s new Emtone device targets cellulite via simultaneous thermal monopolar radiofrequency and mechanical targeted pressure energy to increase production of collagen and elastin. Drew Barrymore is brand ambassador for Emsculpt. Cassiopea has submitted a New Drug Application to the FDA seeking markeOn Purpose, Pediatrics, and Pioneering Care A Conversation with Dr. Lisa Swanson
https://practicaldermatology.com/issues/july-2025/on-purpose-pediatrics-and-pioneering-care-a-conversation-with-dr-lisa-swanson/36514/Young MD Connect recently hosted a mentorship session with pediatric dermatologist Dr. Lisa Swanson to learn from a practicing professional in the field of dermatology in a relaxed “Ask Me Anything” setting.DermWireTV: Cutera, Galderma Acne Treatments; Alma's TED; Diversity Initiatives
https://practicaldermatology.com/topics/practice-management/dermwiretv-cutera-galderma-acne-treatments-almas-ted-diversity-initiatives/20084/There are two new options for treating acne. Cutera introduces the AviClear acne device; Galderma launches Twyneo Cream. Joshua Zeichner, MD weighs in. Lady Dy, MD discusses Alma’s TED device, a non-invasive, non-traumatic option to address hair loss. New initiatives announced at or in conjunction wTreating Moderate to Severe Psoriasis: Weighing the Treatment Options
https://practicaldermatology.com/topics/psoriasis/-treating-moderate-to-severe-psoriasis-weighing-the-treatment-options/18375/In part 2 of her interview with DermTube Journal Club host Joshua Zeichner, MD, Erin Boh, MD reviews new biologics that provide patients with moderate to severe psoriasis improved treatment options. She discusses their efficacy and safety and offers tips for finding the right one for each patient ba